CSL recently opened applications for the 2025 Professor Heimburger Award, an annual program that supports specialists in coagulation, the way blood clots. Conditions such as hemophilia and von Willebrand Disease are coagulation disorders because, in both, a person’s blood does not clot as it should, which can lead to bleeding episodes.
The grant program awards €25,000 (about US $28,000) to five emerging coagulation specialists to pursue research. The award is reserved for MDs and PhDs and applicants with less than five years of clinical practice or postdoctoral research experience will be prioritized. Applications must be received by 11:59pm CET, 11 November 2024.
Learn more about how to apply.
Over the last 18 years, there have been 80+ recipients of the award, all spanning different countries, who have successful research careers within the field and are recognized for their contributions.
“This funding often serves as a mechanism to explore new ideas that can be executed over a one-to-two-year time frame and then serve as a catalyst of, hopefully, larger research projects and additional funding,” said Dr. Steven Pipe, who serves on the Scientific Committee for the Heimburger Award and is a Professor at the University of Michigan, Ann Arbor, where he’s the Medical Director of both the Pediatric Hemophilia and Coagulation Disorders Program and the Special Coagulation Laboratory.
Pipe said the award gives applicants the opportunity to:
- Be at the forefront of cutting-edge research.
- Motivate and inspire the wider research community.
- Strengthen and expand their networks.
- Inspire the next generation of coagulation specialists.
The award honors Professor Dr. Norbert Heimburger, a pioneer of modern coagulation therapy who significantly contributed to the understanding and treatment of coagulation disorders during more than 30 years at CSL Behring, which researches and manufactures medicines for rare conditions.
